Fibrosis is a common process characterized by excessive extracellular matrix (ECM)
accumulation after inflammatory injury, which is also a crucial cause of aging. The process of …

Idiopathic pulmonary fibrosis (IPF) is an age-related fatal disease with unknown etiology and
no effective treatment. In this study, we show that primary cultures of fibroblasts derived from …

Background Exhaled biomarkers may be related to disease processes in idiopathic
pulmonary fibrosis (IPF) however their clinical role remains unclear. We performed a …

Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease with poor
prognosis, which is characterised by destruction of normal lung architecture and excessive …

We aimed to investigate the preventive effect of Infliximab (IFX), a tumor necrosis factor
(TNF)-α inhibitor, on bleomycin (BLC)-induced lung fibrosis in rats. Rats were assigned into …

Background Idiopathic pulmonary fibrosis is a common interstitial lung disease; it is a
chronic, progressive, and fatal lung disease of unknown etiology. Over the last two decades …

Background Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease with limited
treatment options in which the telomere shortening is a strong predictive factor of poor …

Physiology. Sepsis, together with the lung and the heart are the focus of three separate
world health days: World Sepsis Day, World Lung Day, and World Heart Day (Fig. 1) …

Background: Acetaminophen (APAP)-induced liver toxicity remains the key factor limiting the
clinical application of APAP, and herbs are the important sources for isolation of compounds …

Idiopathic pulmonary fibrosis (IPF) is a devastating interstitial lung disease with an incidence
in the United States of 42.7 to 63 per 100,000 and an incidence in Europe of 16.3 to 17.4 per …